Sign Out
Data on the use of Hyoscine-N-Butylbromide in pregnant women are limited.
Animal studies have shown no direct or indirect harmful effects with respect to reproductive toxicity.
Information on the excretion of Hyoscine Butylbromide and its metabolites in breast milk is limited.
As a precaution, during pregnancy and breastfeeding patient should avoid using Hyoscine Butylbromide.
No studies have been conducted on the effects of human fertility.
